Transcriptomics study RNA-SEQ in liver spheroids phase one
Ended Purchase Order Awarded Last action
- Contract number
- 75N95024P00513
- Awardee
-
Insphero, Inc. UEI FCCCVSMNHGJ6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $96,830
Award facts
- Opportunity
-
- Transcriptomics study – RNA-seq in Liver Spheroids Phase One Pre-Solicitation · 75N95024Q00452 · Posted Jul 18, 2024
- Contract value 100% obligated
- $96,829.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Brunswick, ME 04011, USA
Award details come from SAM.gov/FPDS.
About this award
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, has awarded a $96,829.63 firm-fixed-price purchase order to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies. The contract is for a Transcriptomics study - RNA-seq in Liver Spheroids Phase One, with the purpose of evaluating the safety and liver toxicity of candidate antisense oligonucleotides using a 3D liver microtissue platform. This is a non-competitive, sole-source procurement, as the project is a continuation of ongoing work at Insphero. The contract does not utilize any set-aside designations. Insphero has received multiple prior prime and subcontract awards from NCATS and the National Toxicology Program, primarily for providing 3D liver spheroids for drug testing and safety assessments.
Quick answers
Who was awarded contract 75N95024P00513?
75N95024P00513 was awarded to Insphero, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 2, 2024.
How much is contract 75N95024P00513 worth?
The government has obligated $96,830 on 75N95024P00513.
Which agency awarded contract 75N95024P00513?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024P00513, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95024P00513 competed?
The extent of competition for 75N95024P00513 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award